Document Type : Original Article
Authors
Abstract
AIM: To assess the knowledge, attitude, practices (KAP), and barriers regarding pharmacovigilance
and adverse drug reaction (ADR) reporting among medical and dental faculties of the teaching
hospitals.
METHODOLOGY: This study was conducted for a period of 3 months among medical and dental
faculties. A self‑structured, 42‑item closed‑ended questionnaire based on pharmacovigilance and
ADR reporting was used in this study. Data were analyzed using Statistical Package for the Social
Sciences Version 21. All the items of the domains along with demographic variables were summarized
as absolute and relative frequencies. Intergroup comparison was done using Kruskal–Wallis test and
Mann–Whitney U‑test. The correlation between the domains was assessed by Spearman correlation
coefficient.
RESULTS: Among the study subjects, 272 (60.4%) were females and 178 (39.6%) were males.
The number of medical and dental faculties was 360 (80%) and 90 (20%), respectively. The mean
KAP scores for medical and dental faculties were 7.58 and 5.37, 8.78 and 6.01, and 6.91 and 6.32,
respectively. The Spearman correlation coefficient (ρ) was found to be significant for knowledge–
attitude and knowledge–practice domains. The values obtained between attitude with practice and
barrier also were significantly correlated.
CONCLUSION: Our study findings advocate that although medical faculties have better knowledge
about pharmacovigilance and ADR reporting, dentists have a positive attitude, thereby suggesting a
huge scope of progress if more emphasis is given on the need for continuous educational initiatives
and including the topic in their academic curriculum.
Keywords
Reddy, Shravani G Deolia, Yogesh MittalKnowledge, attitude
and practices regarding pharmacovigilance and adverse drug
reaction reporting among dental students in a teaching hospital,
Jodhpur, India: A cross‑sectional study. J Contemporary Dental
Practice 2017;18:964‑69.
2. The Importance of Pharmacovigilance. Safety Monitoring
of Medicinal Products. World Health Organization; 2002.
Available from: https://apps.who.int. [Last accessed on 2019
Oct 15].
3. Jeetu G, Anusha G. Pharmacovigilance: A worldwide master key
for drug safety monitoring. J Young Pharm 2010;2:315‑20.
4. Pharmacovigilance: Ensuring the Safe use of Medicines. WHO
Policy Perspectives on Medicines. Geneva; 2004. Available from:
https://apps.who.int. [Last accessed on 2019 Oct 15].
5. Santosh KC, Tragulpiankit P. Pharmacovigilance: An overview.
Mahidol Univ J Pharma Sci 2011;38:1‑7.
6. Veereen JC, Weiss M. Trends in emergency hospital admissions
in England due to adverse drug reactions: 2008‑2015. J Pharm
Health Serv Res 2017;8:5‑11.
7. Adhikari A, Bhattacharjee N, Bhattacharya S, Indu R, Ray M.
Evaluation of adverse drug reactions in tertiary care hospital of
Kolkata, West Bengal, India. J Young Pharm 2017;9:311‑14.
8. Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation
of knowledge, attitude, and practice of adverse drug reaction
reporting among prescribers at a tertiary care hospital. Perspect
Clin Res 2011;2:129‑36.
9. Lopez‑Gonzalez E, Herdeiro MT, Figueiras A. Determinants of
under‑reporting of adverse drug reactions: A systematic review.
Drug Saf 2009;32:19‑31.
10. Smith CC, Benett PM, Pearce HM, Harisson PI, Reynolds DJ,
Aronson JK, et al. Adverse drug reaction in a hospital general
medicine unit meriting notification to the committee on safety
of medicines. Br J Clin Pharmacol 1996;42:423-42.
11. Madhusudhan SK, Shashikala GH. Evaluation of knowledge,
awareness, and practice of pharmacovigilance among practicing
doctors. Asian J Pharm Clin Res 2016;9:283‑6.
12. Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction
reporting among health care workers at Mulago National
Referral and Teaching Hospital in Uganda. Afr Health Sci
2015;15:1308‑17.
13. Tsugawa Y, Jena AB, Figueroa JF, Orav EJ, Blumenthal DM,
Jha AK. Comparison of hospital mortality and readmission rates
for medicare patients treated by male vs. female physicians. JAMA
Intern Med 2017;177:206‑13.
14. Kumar M, Shravani Deolia, Sangita Totade, Kumar Gaurav
Chabbra, Chaya Chabbra, Shailesh Nagpure Knowledge,
attitude and practices of pharmacovigilance among healthcare
professionals in a medical and dental institute: A comparative
study. Int J Curr Res 2017;9:55139‑144.
15. Torwane NA, Hongal S, Gouraha A, Saxena E, Chavan .
Awareness related to reporting of adverse drug reactions among
health caregivers: A cross sectional questionnaire survey. J Natl
Accredit Board Hosp Healthcare Providers 2015;2:23‑9.
16. Kumar Damodar S, Joseph J, Cheaten S, NanjappanR, Pranav MV,
Guru G. Assessment of knowledge, awareness and practices
among healthcare professionals about pharmacovigilance and
adverse drug reactions reporting in Dharmapuri and Krishnagiri
Districts of Tamil Nadu, India. J Pharm Practice Community
Med 2018;4:33‑8.
17. Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes
and practice of dental doctors about adverse drug reaction
reporting in a teaching hospital in India. Perspect Clin Res
2015;6:144‑49.
18. Mistry CB, Shah SM, Modi VA, Mistry SD Study of
knowledge, attitude, and practices towards current updates of
pharmacovigilance and adverse drug reaction reporting among
doctors in a tertiary care teaching hospital of Western India. Int
J Basic and Clin Pharmacol 2018;7:524‑31.
19. Al Rabayah AA, Hanoun EM, Al Rumman RH. Assessing
knowledge, attitude, and practices of health‑care providers
toward pharmacovigilance and adverse drug reaction reporting
at a comprehensive cancer center in Jordan. Perspect Clin Res
2019;10:115‑20.
20. Singh H, Kumar R. A survey on the knowledge, attitude and the
practice of pharmacovigilance among the health care professionals
in a teaching hospital in Northern India. J Clin Diagnostic Res
2013;7:97‑9.
)